Identification of a human dermal macrophage population responsible for constitutive restraint of primary dermal fibroblast proliferation

Journal of Investigative Dermatology

Volumn 106, Issue 2, 1996, Pages 305-311

  Gonzalez Ramos, Agnes ^a   Cooper, Kevin D ^b,c,d   Hammerberg, Craig ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Dermal Langerhans cell; Flow cytometry; Growth inhibition

Indexed keywords

CD1 ANTIGEN; CD11 ANTIGEN; CYTOKINE;

ARTICLE; CELL PROLIFERATION; FIBROBLAST; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PSORIASIS;

EID: 0029984370     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12342958     Document Type: Article

References (36)

1. Cerio R. Griffiths CEM, Cooper KD, Nickoloff BJ, Headington JT: Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 121:421-431, 1989
2. Headington JT, Cerio R: Dendritic cells and the dermis: 1990. Am J Dermatopathol 12:217-220, 1990
3. Murphy GF, Bhan AK, Harrist TJ, Mihm MC Jr: In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy. Br J Dermatol 108:423-431, 1983
4. + cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol 151:4067-4080, 1993
5. Southeimer RD, Matsubara T, Seelig LL: A macrophage phenotype for a constitutive, class II antigen-expressing, human dermal perivascular dendritic cell. J Invest Dermatol 93:154-159, 1989
6. Weber-Matthiesen K, Sterry W: Organization of the monocyte/macrophage system of normal human skin. J Invest Dermatol 95:83-89, 1990
7. Bos JD, Zonneveld I, Das PK, Krieg SR, van der Loos CM, Kapsenberg ML: The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulation in normal human skin. J Invest Dermatol 88:569-573, 1987
8. Nickoloff BJ: The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 127:523-529, 1991
9. Vilette D, Setiadi H, Wautier M-P, Caen J, Wautier J-L: Identification of an endothelial cell growth-inhibitory activity produced by human monocytes. Exp Cell Res 188:219-225, 1990
10. Elias JA, Jimenez SA, Freundlich B: Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis 135:62-65, 1987
11. Page RC, Davies P, Allison AC: The macrophage as a secretory cell. Int Rev Cytol 52:119-157, 1978
12. Nathan CF: Secretory products of macrophages. J Clin Invest 79:319-326, 1987
13. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH: Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol 106:311-318, 1988
14. Duncan MR, Berman B: Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162:516-527, 1985
15. Elias JA: Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am Rev Respir Dis 138:652-658, 1988
16. Korn JH, Halushka PV, LeRoy EC: Mononuclear cell modulation of connective tissue function. Suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest 65:543-554, 1980
17. Schmidt JA, Mizel SB, Cohen D, Green I: Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 128:2177-2182, 1982
18. Rogalsky V, Svet-Moldavsky I, Arlin Z, Den T, Holland JF: Fibroblast growth inhibitor. Biomed Pharmacol 42:547-554, 1988
19. Jimenez SA, McArthur W, Rosenbloom J: Inhibition of collagen synthesis by mononuclear cell supernates. J Exp Med 150:1421-1431, 1979
20. Freundlich B, Bomalaski JS, Neilson E, Jimenez SA: Regulation of fibroblast proliferation and collagen synthesis by cytokines. Immunol Today 7:303-307, 1986
21. Welgus HG, Campbell EJ, Bar-Shavit Z, Senior RM, Teitelbaum SL: Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest 76:219-224, 1985
22. Saiag P, Coulomb B, Lebreton C, Bell E, Dubertret L: Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 230:669-672, 1985
23. Perlish JS, Fleischmajer R: Immunological modulation of dermal fibroblasts in scleroderma. Immunol Ser 46:605-624, 1989
24. + epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma. Scand J Immunol 32:111-119, 1990
25. Bata-Csorgo ZS, Hammerberg C, Voorhees JJ, Cooper KD: Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 178:1271-1281, 1993
26. Murphy GF, Bronstein BR, Knowles RW, Bhan AK: Ultrastructural documentation of M241 glycoprotein on dendritic and endothelial cells in normal human skin. Lab Invest 52:264-269, 1985
27. Singer KH, Scearce RM, Tuck DT, Whichard LP, Denning SM, Haynes BF: Removal of fibroblasts from human epithelial cell cultures with use of a complement fixing monoclonal antibody reactive with human fibroblasts and monocytes/macrophages. J Invest Dermatol 92:166-170, 1989
28. Goldring SR, Stephenson ML, Downie E, Krane SM, Korn JH: Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts. J Clin Invest 85:798-803, 1990
29. Leslie CC, Musson RA, Henson PM: Production of growth factor activity for fibroblasts by human monocyte-derived macrophages. J Leukoc Biol 36:143-159, 1984
30. Bankey P, Fiegel V, Singh R, Knighton D, Cerra F: Hypoxia and endotoxin induce macrophage-mediated suppression of fibroblast proliferation. J Trauma 29:972-979, 1989
31. Shen HH, Talle MA, Goldstein G, Chess L: Functional subsets of human monocytes defined by monoclonal antibodies: a distinct subset of monocytes contains the cells capable of inducing the autologous mixed lymphocyte culture. J Immunol 130:698-705, 1983
32. Thomas R, Davis LS, Lipsky PE: Isolation and characterization of human peripheral blood dendritic cells. J Immunol 150:821-834, 1993
33. Rennard SI, Bitterman PB, Crystal RG: IV. Mechanisms of fibrosis. Am Rev Respir Dis 130:492-496, 1984
34. Nagao S, Seishima M, Mori S, Nozawa Y: Increased protein kinase C activity in fibroblast membranes from psoriatic patients. J Invest Dermatol 90:406-408, 1988
35. Baadsgaard O, Gupta AK, Taylor RS, Ellis CN, Voorhees JJ, Cooper KD: Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol 92:190-195, 1989
36. + perivascular dendritic cells. J Invest Dermatol 96:333-340, 1991